Jul 10, 2026
14 MIN READ

NAD+ vs Mounjaro — Which Works Better for Weight Loss?

NAD+ and tirzepatide target weight loss through completely different biological pathways. Tirzepatide activates dual GLP-1 and GIP receptors to reduce hunger and improve metabolism, while NAD+ supports cellular energy. Understanding your genetic profile helps determine which approach fits your we...

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jul 10, 2026
14 MIN READ

nad+ vs mounjaro — which works better for weight loss? — PlexusDx GLP-1 education

Last reviewed: July 10, 2026

Last updated: July 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weight loss strategies often overlap in marketing but differ drastically in mechanism. NAD+ boosters focus on cellular energy production, while tirzepatide—a GLP-1 and GIP receptor agonist—directly signals your brain to reduce appetite and food intake. Clinical data shows tirzepatide produces measurable weight reduction in most patients, whereas NAD+ evidence remains limited to cellular aging research.

How Tirzepatide Works for Weight Loss

Tirzepatide activates two distinct hormone receptors in your brain and gut: the GLP-1 receptor and the GIP receptor. This dual action slows gastric emptying, increases feelings of fullness, and reduces your drive to eat. Unlike stimulant-based weight loss approaches, tirzepatide works with your body's natural hunger-regulation system rather than against it.

Clinical trials show tirzepatide produces dose-dependent weight loss of 15–22% over 68 weeks in patients with obesity. The medication also improves blood sugar control and cardiovascular markers, making it effective for people with type 2 diabetes or metabolic syndrome. PlexusDx offers compounded tirzepatide injections starting at $249/mo, with your dose able to increase without price increases—allowing your treatment to scale with your progress.

Understanding NAD+ and Cellular Energy

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that powers mitochondrial function, the energy-producing centers of your cells. Declining NAD+ levels are linked to aging, reduced energy availability, and slower metabolism in some research models. NAD+ boosters (like NMN or NR) attempt to restore these levels, theoretically improving energy and metabolic rate.

However, clinical evidence for NAD+ supplementation in human weight loss remains sparse. Most NAD+ research focuses on longevity and age-related decline in laboratory settings, not sustained weight reduction in real patients. Unlike tirzepatide's proven receptor signaling, NAD+ benefits rely on indirect metabolic improvements that are difficult to measure and replicate across populations.

Tirzepatide vs NAD+ — Key Differences in Action

Tirzepatide's strength lies in direct appetite suppression: it tells your brain you're full sooner and keeps you satisfied longer. This creates a calorie deficit that translates to measurable weight loss. NAD+ works theoretically by enhancing cellular energy capacity, which may support exercise tolerance but does not directly reduce hunger or food intake.

Another critical difference is reversibility. When you stop tirzepatide, hunger signals return to baseline within days. When you stop NAD+ boosters, any cellular energy support dissipates gradually. For weight loss sustainability, tirzepatide's active appetite control often outperforms passive metabolic enhancement. PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on) to identify your genetic sensitivity to GLP-1 and GIP pathways, helping predict your individual response to tirzepatide therapy.

Why Genetic Testing Matters for Weight Loss Choice

Not every patient responds equally to tirzepatide or other GLP-1 therapies. Variations in your GLP1R gene (rs6923761) and GIPR gene (rs1800437) influence how strongly you respond to these medications. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to reveal your genetic predisposition to appetite-regulating hormones.

If your genetic profile shows strong GLP-1 and GIP sensitivity, tirzepatide becomes an excellent first-line choice—you're more likely to experience meaningful appetite suppression and weight loss. If your profile suggests lower receptor sensitivity, PlexusDx can adjust dosing strategy or explore alternative compounds like semaglutide or the dual-compound GLP-Squared injection. This precision approach eliminates guesswork and NAD+'s undefined pathway, delivering personalized results from day one.

Cost, Access, and Sustainability

PlexusDx tirzepatide injections begin at $249/mo through licensed 503A compounding pharmacies and are available in all 50 states without insurance or membership fees. HSA/FSA cards accepted. NAD+ supplements range from $30–$150/month but carry no clinical weight loss guarantee and no medical oversight of dose or purity.

For long-term weight management, tirzepatide offers clarity: a known mechanism, measurable results, medical supervision, and transparent pricing that doesn't increase with dose escalation. Your dose may need to go up as your body adjusts, but your price won't. NAD+ remains an unproven, indirect strategy with mounting supplement costs and uncertain metabolic benefit for weight loss specifically.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I combine NAD+ and tirzepatide for better weight loss?

Combining them is theoretically possible but not studied together. Tirzepatide alone produces sufficient weight loss for most patients; adding NAD+ would increase cost without proven additional benefit. PlexusDx recommends optimizing tirzepatide dosing and monitoring your response before layering additional compounds.

Does NAD+ boost metabolism enough to replace tirzepatide?

No. NAD+ enhances cellular energy capacity, but clinical trials don't show meaningful weight loss from NAD+ alone. Tirzepatide directly suppresses appetite and produces 15–22% weight loss in clinical studies, a measurable outcome NAD+ has not replicated in human trials.

How much does PlexusDx tirzepatide cost compared to brand-name Mounjaro?

PlexusDx compounded tirzepatide injections start at $249/mo across all commitment tiers, with no insurance required. Brand-name Mounjaro typically costs $900–$1,200/mo even with insurance. PlexusDx pricing remains flat regardless of dose escalation.

What are the side effects of tirzepatide vs NAD+ supplements?

Tirzepatide may cause nausea, constipation, or appetite loss—side effects tied directly to its intended appetite-suppressing action and typically mild and temporary. NAD+ supplements are generally well-tolerated but can cause headache or nausea at high doses; however, their lack of direct action means fewer expected side effects overall. Tirzepatide requires medical oversight; NAD+ does not.

Will the Precision Peptide Genetic Test tell me if NAD+ or tirzepatide is better for me?

The test maps your GLP-1R, GIPR, FTO, and MC4R genetic variants to predict your sensitivity to appetite-regulating peptides and hormones. This directly predicts tirzepatide response but doesn't assess NAD+ pathways, since NAD+ lacks receptor-specific genetics tied to weight loss. The test is designed to optimize tirzepatide and GLP-1 therapy selection and dosing.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves